News & Events

New publication: Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia

12/05/21

See more

First patient included in the PREV-HAP study!

29/03/21

See more

First Site Initiation Visit completed for the PREV-HAP study

22/03/21

See more

Jean Valade prize awarded to Pr. Antoine Roquilly

19/03/21

    Press release (in French)

See more

New HAP2 status meeting

17/02/21 - 18/02/21

See more

1st HAP2 paper published!

26/01/21

See more

Wedata’s avatars solution certified by the French Data Protection Authority

05/11/20

See more

PREV-HAP investigators’ meeting

24/11/20

See more

Clinical study “PREV-HAP” submitted for approval

30/10/20

See more

HAP2 leaflet now available

26/03/20

This leaflet contains a concise overview of the project’s concept and objectives; the presentation of two clinical trials conducted within the project; and highlights the various outputs we will offer to patients...

See more

HAP2 kick-off meeting

13/01/20 - 14/01/20

All partners attended the 2-day meeting, filled with enthusiasm and collaboration as we planned the first year of the project. Over 2020, we’ll be focused on planning for our two clinical trials:...

See more